Conflicts of Interest: A Case Study of Canada
Ms. Deanna McCleod provides an overview of the gaps in the checks and balances in the creation of guidelines surrounding the management of COVID-19.
Ms. Deanna McCleod provides an overview of the gaps in the checks and balances in the creation of guidelines surrounding the management of COVID-19.
Nuvaxovid is the brand name for the Novavax COVID-19 vaccine. It is not an mRNA vaccine like Pfizer and Moderna’s versions.
The College of Physicians and surgeons of Ontario recently released their deliberations on a motion hearing by three Ontario physicians. The three medical doctors have had their licenses suspended for acting outside the recommendations of their regulatory college thus providing individualized care to their patients.
Dr. Patrick Provost is a faculty member of Laval University. He shares his experiences with being suspended from his university for publicly challenging the consensus regarding COVID-19 genetic vaccines, particularly for children.
Dr. Claudia Chaufan’s article is an analysis of the medical messaging relating to COVID-19 and the issues with unchallenged consensus.
The CCCA’s open letter and critique in response to the report recently issued by the Council of Canadian Academies (CCA).
Deanna McLeod’s interview on Open Mike with Mr. Michael Thiessen, on the topic of conflicts of interests surrounding the COVID-19 injections.
In this peer-reviewed publication, Dr Patrick Provost examines the post-vaccination adverse events reporting system and the inherent weaknesses that may result in underreporting. Based on
Dr. Aseem Malhotra, an esteemed cardiologist from the United Kingdom, is interviewed about the real risks shown from the COVID-19 genetic vaccine trials.
A Rejoinder to Ogden et al.’s “Counterfactuals” of Effects of Vaccination and Public Health Measures on COVID-19 Cases in Canada: What could have Happened?” Members
ENTER YOUR SEARCH TERMS AND HIT ENTER